Technology Platform
CELLshot's facial care technology is built on the tiptop regenerative science platform,
an innovative platform translating regenerative medicine into everyday skincare.
Targeted signal transduction · Precision cellular intervention based on tissue-compatible signaling.
Freeze-Drying Technology
Lyophilization preserves the bioactivity of active ingredients. Activation immediately before use ensures maximum efficacy.
Dual-Chamber System
Active ingredients and solvent stored separately. Mixing before use completely prevents oxidation and degradation.
Evidence-Based Foundation
36 peer-reviewed papers published in Nature and Science support our technology platform.
JCIA Registration
Japan's only registered human endometrial stem cell exosome product with JCIA.
GESS Standards Compliant
Quality management in compliance with the Global Exosome Safety Standard (GESS).
Selected Publications
Nature
p63⁺Krt5⁺ distal airway stem cells are essential for lung regeneration
DOI: 10.1038/nature13903Science Translational Medicine
Autologous transplantation of P63⁺ lung progenitor cells for COPD therapy
DOI: 10.1126/scitranslmed.adi3360J Extracell Vesicles
MISEV2018: Guidelines for extracellular vesicle researchers
DOI: 10.1080/20013078.2018.1535750Technology Foundation Details
CELLshot's technology is rooted in the tiptop regenerative science platform.
For full scientific foundation, publications, and pipeline details, visit the tiptop platform.
Learn More
For more details on technology and evidence, explore the pages below.
